These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25730617)

  • 21. B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE.
    Iwata S; Saito K; Tokunaga M; Tanaka Y
    Ann Rheum Dis; 2012 Oct; 71(10):1749-50. PubMed ID: 22586167
    [No Abstract]   [Full Text] [Related]  

  • 22. Melanocortin in the Pathogenesis of Inflammatory Eye Diseases: Considerations for Treatment.
    Retina; 2018 Oct; 38 Suppl 1():1-12. PubMed ID: 30339562
    [No Abstract]   [Full Text] [Related]  

  • 23. Biological response modifier therapy for refractory childhood uveitis.
    Gallagher M; Quinones K; Cervantes-Castañeda RA; Yilmaz T; Foster CS
    Br J Ophthalmol; 2007 Oct; 91(10):1341-4. PubMed ID: 17556427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cyclosporine therapy of refractive uveitis].
    Fujino Y; Nakamura M; Nishiyama A; Tabuchi S; Hijikata K; Masuda K; Mochzuki M
    Nippon Ganka Gakkai Zasshi; 1987 Jul; 91(7):686-93. PubMed ID: 3501241
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical and immunological criteria for predicting the course of uveitis].
    Chentsova OB
    Vestn Oftalmol; 1999; 115(2):23-5. PubMed ID: 10377869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [T- and B-lymphocyte populations in deep forms of ocular herpes].
    Mal'khanov VB
    Vestn Oftalmol; 1982; (2):38-40. PubMed ID: 6979123
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy-resistant cells of the B cell line].
    Hoyer BF; Dörner T
    Z Rheumatol; 2016 Aug; 75(6):556-9. PubMed ID: 27379736
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunology of uveitis and ocular allergy.
    Zierhut M; Schlote T; Tomida I; Stiemer R
    Acta Ophthalmol Scand Suppl; 2000; (230):22-5. PubMed ID: 11057345
    [No Abstract]   [Full Text] [Related]  

  • 29. [Selected immunologic parameters in uveitis].
    Wieczorek E; Hańczyc P; Prastowska E
    Klin Oczna; 1989 Jan; 91(1):14-6. PubMed ID: 2811187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.RIII mice.
    Chen J; Vistica B; Wiggert B; Chan CC; Gery I
    Ocul Immunol Inflamm; 2005 Feb; 13(1):13-7. PubMed ID: 15804764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological response modifiers in the small bowel allograft rejection.
    Zorraquino MN
    Nutr Hosp; 1995; 10(1):1-6. PubMed ID: 7711145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab for humoral rejection after kidney transplantation: an update.
    Rostaing L; Guilbeau-Frugier C; Kamar N
    Transplantation; 2009 Apr; 87(8):1261. PubMed ID: 19384176
    [No Abstract]   [Full Text] [Related]  

  • 34. B cells in SLE: different biological drugs for different pathogenic mechanisms.
    Diamanti AP; Rosado MM; Carsetti R; Valesini G
    Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding autoimmune disease: new targets for drug discovery.
    Balagué C; Kunkel SL; Godessart N
    Drug Discov Today; 2009 Oct; 14(19-20):926-34. PubMed ID: 19596080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Circulating immune complexes in children with uveitis].
    Hańczyc P; Wieczorek E; Prastowska E; Prusek W
    Klin Oczna; 1989 Jan; 91(1):12-4. PubMed ID: 2811186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular immunity in pediatric uveitis.
    Bakunowicz-Lazarczyk A; Antosiuk R; Wysocka J; Sulkowska M
    Int J Tissue React; 2001; 23(4):137-43. PubMed ID: 11771777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New biological therapy in systemic lupus erythematosus].
    Morita K; Fujio K
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():539-44. PubMed ID: 23513898
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunologic peculiarities of uveitis concurrent with systemic pathologies].
    Drozdova EA; Tarasova LN; Teplova SN; Alekhina TV
    Vestn Oftalmol; 2004; 120(4):24-6. PubMed ID: 15384843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune diseases. The B cell slayer.
    Matthews R
    Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.